Toggle light / dark theme

Dopamine in Fear Extinction

The ability to extinguish fear memories when threats are no longer present is critical for adaptive behavior. Fear extinction represents a new learning process that eventually leads to the formation of extinction memories. Understanding the neural basis of fear extinction has considerable clinical significance as deficits in extinction learning are the hallmark of human anxiety disorders. In recent years, the dopamine (DA) system has emerged as one of the key regulators of fear extinction. In this review article, we highlight recent advances that have demonstrated the crucial role DA plays in mediating different phases of fear extinction. Emerging concepts and outstanding questions for future research are also discussed.

Learning to associate stimuli and situations with danger or safety is critical for survival and adaptive behavior. In the laboratory, these forms of learning are typically studied using Pavlovian fear conditioning and extinction. Fear conditioning is an example of associative learning in which an initially neutral stimulus such as a tone (conditioned stimulus, CS) comes to elicit fear responses after being paired in time with an aversive outcome such as a foot shock (unconditioned stimulus, US). Once the CS-US association is learned, subsequently repeated presentations of the CS in the absence of the aversive US result in a gradual decrease in conditioned fear responses, a process known as fear extinction. In the last decades, fear extinction has attracted much interest in part because deficits in extinction learning are thought to underlie human anxiety disorders, such as post-traumatic stress disorder (PTSD) and phobias (Graham and Milad, 2011; Pitman et al., 2012; Craske et al.

Groundbreaking Biomaterial Heals Tissues From the Inside Out

The substance can be administered via intravenous injection and holds the possibility of being used in the treatment of conditions such as heart attacks and traumatic brain injury, among others.

An innovative biomaterial has been developed that, when injected intravenously, reduces inflammation and stimulates cell and tissue repair. The efficacy of this biomaterial in treating heart attack-induced tissue damage was demonstrated through successful testing on both rodent and large animal models. The researchers also provided proof of concept, based on a rodent study, suggesting that the biomaterial may prove beneficial in the treatment of traumatic brain injury and pulmonary arterial hypertension.

“This biomaterial allows for treating damaged tissue from the inside out,” said Karen Christman, a professor of bioengineering at the University of California San Diego, and the lead researcher on the team that developed the material. “It’s a new approach to regenerative engineering.”

Dr. Doug Ethell — Founder & CEO, Leucadia Therapeutics — Diagnosing, Treating & Curing Alzheimer’s

Diagnosing, Treating & Curing Alzheimer’s — Dr. Doug Ethell, PhD — Founder & CEO, Leucadia Therapeutics


Dr. Doug Ethell, Ph.D. is Founder and CEO at Leucadia Therapeutics (https://www.leucadiatx.com/), a pre-clinical-stage company focused on diagnosing, treating and curing Alzheimer’s disease.

Leucadia’s proprietary Arethusta® medical device is designed to restore the flow of cerebrospinal fluid (CSF) through the cribriform plate to flush toxins away from the part of the brain where Alzheimer’s disease first appears. The company also recently launched eight Apps that help exercise memory and cognition, including a personalized memory tracker called ProCogny (www.procogny.com). ProCogny allows users to play memory-intensive puzzles and games, daily Brain Boost collections of mini-puzzles, and a non-clinical version of the Leucadia Memory Test.

Dr. Ethell received a Ph.D. in Neurobiology from The University of British Columbia in Vancouver, was a Human Frontiers of Science Long Term Fellow at The Max Planck Institute for Psychiatry in Munich, a Staff Scientist at The Scripps Research Institute and La Jolla Institute for Allergy & Immunology, and a faculty member at the University of California Riverside.

In 2017, Dr. Ethell was Professor of Neuroscience, Chair of Graduate Faculty, and Head of Molecular Neurobiology at The Western Univ of Health Sciences before joining Leucadia Therapeutics full-time. He has published more than 85 peer-reviewed articles and presentation abstracts.

New Study Finds Neurons Derived from Stem Cells Predict Psychosis and Cognitive Deficits in Individuals with Schizophrenia

Baltimore, Md. (January 11, 2022) – In a breakthrough that holds significant promise for early diagnosis and better treatment of psychiatric illness, researchers have for the first time used neurons derived from human stem cells to predict the cardinal features of a psychiatric illness, such as psychosis and cognitive deficits in patients with schizophrenia.

A study published today in the Proceedings of the National Academy of Sciences (PNAS) by scientists at the Lieber Institute for Brain Development/Maltz Research Laboratories (LIBD) shows that the clinical symptoms of individuals with schizophrenia can be predicted by the activity of neurons derived from the patients’ own stem cells.

This connection — between the physiology of cells and symptoms like delusions, hallucinations and altered cognition— has never been made before. That is, no other study has demonstrated a robust association between neuronal models derived from a patient’s stem cells and clinically relevant features of the psychiatric disorder in the same person.

What is Consciousness? | Unveiled

How are you a conscious being?? Join us, and find out!

Subscribe for more ► https://wmojo.com/unveiled-subscribe.

In this video, Unveiled takes a closer look at human consciousness! It’s a topic that has intrigued and bemused scientists and philosophers for years… but are we FINALLY close to reaching an answer?? What is consciousness? Where is consciousness? And does it exist apart from our bodies??

This is Unveiled, giving you incredible answers to extraordinary questions!

Find more amazing videos for your curiosity here:
Parallel Universe Stories to Make You Question Reality — https://youtu.be/1QvShWXCHEQ
Did Scientists Just Discover a Theory of Everything? — https://youtu.be/nGUWJYVCsp4

0:00 Intro.

Crabs Have Evolved Five Separate Times—Why Do the Same Forms Keep Appearing in Nature?

It’s not only body forms that evolve independently, but also organs and other structures. Humans have complex camera eyes with a lens, iris and retina. Squid, and octopuses, which are molluscs and more closely related to snails and clams, also evolved camera eyes with the same components.

Eyes more generally may have evolved independently up to 40 times in different groups of animals. Even box jellyfish, which don’t have a brain, have eyes with lenses at the bases of their four tentacles.

The more we look, the more we find. Structures such as jaws, teeth, ears, fins, legs and wings all keep evolving independently across the animal tree of life.

Scientists Found a Multidimensional Universe Right Inside Our Brain

Experts have discovered that the human brain has structures and forms with up to 11 dimensions, which is a remarkable finding. “We discovered a realm that we had never envisaged,” neuroscientists said of the finding. Algebraic topology mathematical approaches have aided researchers in discovering structures and multidimensional geometric spaces in brain networks. A recent study, according to specialists, has demonstrated that the human brain has structures and forms with up to 11 dimensions. According to Science Alert, our brains have an estimated 86 billion neurons, with many connections from each cell stretching in every imaginable direction, making a super-vast cellular network that SOMEHOW allows us to think and be conscious.

/* */